InvestorsHub Logo
icon url

daBoze

07/25/11 7:18 AM

#52866 RE: SparkyinIowa #52865

This report on HIV-cide seems to be a step back from the "functional cure" previously reported. The good news, however, is that the process lends itself to the same optimization as seen in the Flu-cide studies which will possibly lead to the functional cure being sought. This further solidifies Flu-cide as the lead candidate for the initial NDA.
icon url

TheDane

07/25/11 9:01 AM

#52879 RE: SparkyinIowa #52865

This looks like Excellent News! to me and seems packed with information that will take some time for investors to chew on. I see no retreat from previous reports on HIV-cide. This seems to be written to support the ongoing "optimization" program for each Cide and the current strategy for preparing for an IND.

BWDIK?
icon url

Echo20

07/25/11 9:37 AM

#52882 RE: SparkyinIowa #52865

Sparky4nnvc

Maybe the equal to HAART will get through the FDA better.

The NO TOXIC results could be the winning point.

Is the HAART drug the one pill a day program?

Echo20